Literature DB >> 21187063

Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease.

D'Vesharronne Moore1, Catherine McNeal, Ronald Macfarlane.   

Abstract

Apolipoprotein C-I (apoC-I) is a 6.6kDa serum protein associated with high density lipoproteins (HDL) and triglyceride-rich lipoproteins. In this study, apoC-I was examined in high density lipoprotein subfractions from individuals with and without coronary artery disease (CAD). New isoforms of apoC-I, were detected in the cohort of individuals with CAD using mass spectrometry while the expected apoC-I isoforms were absent. In addition, the apoC-I mass spectra for the CAD cohort had satellite peaks indicative of the involvement of oxidative processes. Further analysis of the mass spectra of the CAD and non-CAD cohorts suggest that the origin of these new isoforms may be due to genetic mutations that could compromise the function of apoC-I.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187063      PMCID: PMC3031731          DOI: 10.1016/j.bbrc.2010.12.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.

Authors:  A K Soutar; C W Garner; H N Baker; J T Sparrow; R L Jackson; A M Gotto; L C Smith
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

2.  Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins.

Authors:  R S Shulman; P N Herbert; K Wehrly; D S Fredrickson
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

3.  Intracellular modification of human apolipoprotein AII (apoAII) and sites of apoAII mRNA synthesis: comparison of apoAII with apoCII and apoCIII isoproteins.

Authors:  M M Hussain; V I Zannis
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

Review 4.  Proteolytic events affecting plasma apolipoproteins at the co- and post-translational levels and after maturation.

Authors:  A M Scanu; R E Byrne; C Edelstein
Journal:  J Lipid Res       Date:  1984-12-15       Impact factor: 5.922

5.  Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity.

Authors:  T Gautier; D Masson; J P de Barros; A Athias; P Gambert; D Aunis; M H Metz-Boutigue; L Lagrost
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase.

Authors:  Karin Conde-Knape; André Bensadoun; Joan H Sobel; Jeffrey S Cohn; Neil S Shachter
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

7.  HDL in humans with cardiovascular disease exhibits a proteomic signature.

Authors:  Tomás Vaisar; Philip Mayer; Erik Nilsson; Xue-Qiao Zhao; Robert Knopp; Bryan J Prazen
Journal:  Clin Chim Acta       Date:  2010-03-20       Impact factor: 3.786

8.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

Authors:  R C Kowal; J Herz; K H Weisgraber; R W Mahley; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  Synthesis, intracellular processing, and signal peptide of human apolipoprotein E.

Authors:  V I Zannis; J McPherson; G Goldberger; S K Karathanasis; J L Breslow
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

10.  Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase.

Authors:  Antonina Kolmakova; Peter Kwiterovich; Donna Virgil; Petar Alaupovic; Carolyn Knight-Gibson; Sergio F Martin; Subroto Chatterjee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-11       Impact factor: 8.311

View more
  4 in total

1.  Human HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis.

Authors:  Catherine J McNeal; Subroto Chatterjee; Jennifer Hou; London S Worthy; Craig D Larner; Ronald D Macfarlane; Petar Alaupovic; Robert W Brocia
Journal:  Cardiovasc Res       Date:  2013-01-25       Impact factor: 10.787

2.  Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular disease.

Authors:  Craig D Larner; Ronald R Henriquez; Jeffrey D Johnson; Ronald D Macfarlane
Journal:  Anal Chem       Date:  2011-10-18       Impact factor: 6.986

Review 3.  Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.

Authors:  Chiz-Tzung Chang; Chao-Yuh Yang; Fuu-Jen Tsai; Shih-Yi Lin; Chao-Jung Chen
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 4.  Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.

Authors:  Elena V Fuior; Anca V Gafencu
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.